| Patent title | Granted | Pending | |
| Taiwan | 後生元提取物的製備方法以及由該方法所得到的產物及其用於抑制生物膜形成與促進腸道健康之用途。 A method for preparing postbiotic extract, and its products obtained therefrom for inhibiting biofilm formation and promoting intestinal health. |
TW I733446 | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. |
TW I739424 | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. |
TW I748448 | ||
| 具有核殼結構的益生菌顆粒。 Probiotic particles with nuclear-shell structure. |
TW M602905U | ||
| 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷。 The use of heat-killed Lactobacillus strains for treating and/or preventing particulate matter-induced lung injury. |
TW I802009 | ||
| 使用一包含有植物乳桿菌 CB102 分離株與燕窩酸的組合來改善皮膚病況。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid for improving skin conditions. |
TW I808582 | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. |
112120383 | ||
| 具穩定包覆活性成分能力之複合結構保健品。 A composite structural health supplement with the ability for stable encapsulation of active ingredients. |
112212381 | ||
| China | 後生元提取物的製法以及該方法得到的產物及其抑制生物膜形成與促進腸道健康的用途。 The method of preparing postbiotic extract, the product obtained by the method, and its use for inhibiting biofilm formation and promoting intestinal health. |
202010601125.5 | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. |
202010601311.9 | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. |
202010601261.4 | ||
| 具有核殼結構的益生菌顆粒及益生菌軟膠囊。 Probiotic particles with nuclear-shell structure and probiotic soft capsules. |
CN 213549547U | ||
| 熱致死的乳酸菌菌株作為製備治療和/或預防微粒物質-誘發的肺損傷的醫藥品的用途。 The use of heat-killed Lactobacillus strains as a pharmaceutical preparation for the treatment and/or prevention of particulate matter-induced lung injury. |
202111291686.0 | ||
| 包含植物乳桿菌 CB102 與燕窩酸的組合在製備用來改善皮膚病況的組合物中的用途。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid in the preparation of a composition for improving skin conditions. |
202211396626.X | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. |
202310870474.0 | ||
| 具有穩定包覆活性成分能力之複合結構保健品。 A composite structural health supplement with the ability for stable encapsulation of active ingredients. |
202323294033.5 | ||
| USA | POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF | US 11541085 B2 | |
| METHOD FOR ALLEVIATING ARTHRITIS WITH POSTBIOTIC EXTRACT | US 11517596 B2 | ||
| METHOD FOR IMPROVING SKIN CONDITION WITH POSTBIOTIC EXTRACT | US 11517597 B2 | ||
| METHOD FOR PREVENTING OR ALLEVIATING PARTICULATE MATTER-INDUCED LUNG INJURY | 17/529474 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF "splitting case" (inhibiting biofilm formation) | 18/051968 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF "Splitting case" (promoting intestinal health) | 18/051983 | ||
| METHOD OF USING A COMBINATION OF POSTBIOTICS AND PROBIOTICS FOR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION-ASSOCIATED DISORDERS. | 18/499450 |
| Year | Papers title | Journal / Exhibition name |
| 2023 | 後生元協同益生菌減輕由 PM2.5 引起的肺損傷及過敏。 Synergistic effect of probiotic and postbiotic on attenuation of PM2.5-induced lung damage and allergic response. |
J Food Sci. 2023;88(1):513-522. doi:10.1111/1750-3841.16398 |
| 久司酵素增強版透過纖維與體內油脂結合與促進排出來改善腸道健康。 BraziZyme® PLUS improves gastrointestinal health through its fiber-mediated binding and excretion of intracellular lipids . | 2023 台灣乳酸菌協會研討會。 2023 Taiwan Association for Lactic Acid Bacteria Conference. |
